Navigation Links
UCSF transgenic mouse mimics Parkinson's earliest symptoms
Date:5/3/2010

UCSF researchers have created the first transgenic mouse to display the earliest signs of Parkinson's disease using the genetic mutation that is known to accompany human forms of the disease.

The mouse model, which expresses the same mutant proteins as human Parkinson's patients, also displays early signs of constipation and other gastrointestinal problems that are a common harbinger of the disease in humans.

As a result, researchers say, these animals could serve as a means of investigating therapies for reversing the neurological dysfunction of the disease at its earliest stages.

The findings are featured as the cover story in the May 1, 2010 issue of the journal, "Human Molecular Genetics" and are available online at http://hmg.oxfordjournals.org/cgi/content/full/19/9/1633.

Researchers have long suspected that the neurological component of Parkinson's, which causes tremors and stiffness among other symptoms, is actually a late-stage effect of a larger, systemic problem, according to UCSF geneticist Robert L. Nussbaum, MD, who was senior author on the paper.

"This new model validates that theory by mimicking what we know to be the genetic pathway leading to Parkinson's, while also displaying the earliest symptoms that occur in humans," said Nussbaum, who is the Holly Smith Distinguished Professor in Medicine and chief of the UCSF Division of Medical Genetics. "This will give us an important tool in identifying an early intervention for this devastating disease."

Parkinson's disease is the second most common neurodegenerative disease after Alzheimer's, affecting 1.5 percent of adults over 55 years of age, and is typically characterized by motor disorders such as tremors, rigidity and postural instability.

Several non-motor abnormalities also frequently accompany Parkinson's, including depression, sleep disorders and ga
'/>"/>

Contact: Kristen Bole
kbole@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Yerkes researchers create first transgenic prairie voles
2. Transgenic songbirds provide new tool to understand the brain
3. Risks involved with transgenic fish
4. First draft of transgenic papaya genome yields many fruits
5. Is transgenic cotton more profitable?
6. Transgenics transformed
7. Transgenic maize is more susceptible to aphids
8. Intentional variation increases result validity in mouse testing
9. Mouse work: New insights on a fundamental DNA repair mechanism
10. Stem cells restore sight in mouse model of retinitis pigmentosa
11. Penn biologists determine microRNA activity is suppressed in mouse ovum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... Washington, DC Monday, September 29: Between 1970 ... and fish around the globe dropped 52 percent, ... by World Wildlife Fund (WWF). This biodiversity loss ... increasing resource use of high-income countries. , In ... the report,s data point to other warning signs ...
(Date:9/29/2014)... school? According to a new Food and Brand Lab ... can increase participation in the National School Lunch Program ... vegetables by 16%! , Chefs Move to Schools (CMTS), ... chefs with schools in order to provide nutrition instruction ... service workers. , A CMTS event was held in ...
(Date:9/29/2014)... team says recently identified radiation detection properties of a ... for homeland security and medical advances. , In a ... of Optics Letters , UT Arlington Physics Professor ... to fabricate transparent nanoscintillators by heating nanoparticles composed of ... formed. A scintillator refers to a material that ...
Breaking Biology News(10 mins):Half of global wildlife lost, says new WWF report 2Chefs move to schools can increase school meal participation and vegetable intake among students 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 3
... y MUNICH, 7 de noviembre de 2012 Bausch + ... ejercitación de su opción de compra de todas las acciones ... Vision GmbH (TPV), una destacada compañía láser de oftalmología. ... de una sociedad mixta entre Bausch + Lomb y 20/10 ...
... 2012 Bausch + Lomb, a empresa global de saúde ... as ações em circulação e sem controle da Technolas ... A Technolas Perfect Vision foi criada em 2009 ... + Lomb e a 20/10 PERFECT VISION AG para desenvolver ...
... well known for attacking a protein associated with the ... it also degraded a different protein that triggers blood ... a key challenge in the battle against cancer, according ... in the University of Leeds, Faculty of Biological Sciences., ...
Cached Biology News:Bausch + Lomb adquiere Technolas Perfect Vision GmbH 2Bausch + Lomb adquiere Technolas Perfect Vision GmbH 3Bausch + Lomb adquiere Technolas Perfect Vision GmbH 4Bausch + Lomb prestes a adquirir a Technolas Perfect Vision GmbH 2Bausch + Lomb prestes a adquirir a Technolas Perfect Vision GmbH 3Bausch + Lomb prestes a adquirir a Technolas Perfect Vision GmbH 4Breast cancer drug could halt other tumors 2
(Date:9/30/2014)... in German . ... dots in a semiconductor layer. Quantum dots are small structures ... If a short laser pulse is fired at the photonic ... experiences a change in the electromagnetic field around it. This ... light by the dot. As soon as the refractive index ...
(Date:9/30/2014)... Using a bio-mimicking analog of one of nature,s ... international research team led by Alejandro Briseno of ... major step in developing long-sought polymer architecture to ... use in electronic devices. , Briseno, with ... others at Stanford University and Dresden University of ...
(Date:9/30/2014)... 30, 2014 Shimadzu Scientific Instruments ... easy-to-use and highly precise tool for measuring displacement ... elongation. With 1000-mm maximum movement distance, the DSES-1000 ... a gauge length of 10 mm. In addition, ... above 50-mm stroke and within +/- 100 µm ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Proove ... medicine, is excited to announce a new genetic test ... The Proove Pain Perception Test will provide physicians ... and why pain tolerance levels are stratified between individuals. ... identify whether a person has a genetic predisposition that ...
Breaking Biology Technology:Ultrafast remote switching of light emission 2Blades of grass inspire advance in organic solar cells 2Blades of grass inspire advance in organic solar cells 3Shimadzu’s New Long-Travel Extensometer Increases Precision for Soft Material Testing 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3
... - YM BioSciences Inc. (NYSE Amex: YMI ... company that identifies and advances a diverse portfolio ... development, today reported that its licensee for nimotuzumab, ... has commenced enrollment of a Phase II trial ...
... and to Complete Current Phase 3 Trial of Naturlose(R) ... June 23 Spherix Incorporated (Nasdaq: SPEX ... a provider of technical and regulatory consulting services to ... it has received its first full-scale production batch of ...
... Medical Device & Diagnostic Industry Magazine,s 30 Years, 30 Devices Special ... 23 Medical Device and Diagnostic Industry has recognized ... a leader in infusion therapy and pain management as well as ... as being among the most influential medical devices of the last ...
Cached Biology Technology:YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 2YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 3YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 4YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 5Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 2Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 3Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 4B. Braun Medical Inc. Recognized by Industry for Manufacturing Influential Medical Devices 2B. Braun Medical Inc. Recognized by Industry for Manufacturing Influential Medical Devices 3B. Braun Medical Inc. Recognized by Industry for Manufacturing Influential Medical Devices 4
Rabbit polyclonal to hnRNP-U...
... iTaq DNA polymerase is ... suitable for both conventional and ... is supplied at a concentration ... and includes 250 units polymerase, ...
... (E.C. 3.1.21.1) is a nonspecific endonuclease that ... functions by hydrolyzing phosphodiester linkages, producing mono ... 3'-hydroxyl group. Ambion's RNase-free DNase I is ... recommended to degrade DNA in the presence ...
RABBIT ANTI RHEB (IN) Immunogen: A 15 amino acid peptide located in the central region of human Rheb....
Biology Products: